Bank Julius Baer & Co. Ltd, Zurich Quanterix Corp Transaction History

Bank Julius Baer & Co. Ltd, Zurich

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$37.54 - $57.51 $469,250 - $718,875	-12,500 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$45.91 - $59.67 $12.6 Million - $16.3 Million	-273,896 Reduced 95.64%	12,500 $622,000
Q2 2021 Jul 23, 2021	BUY	$43.3 - $67.17 $1.69 Million - $2.62 Million	39,010 Added 15.77%	286,396 $16.8 Million
Q1 2021 May 10, 2021	BUY	$44.11 - $90.64 $10.4 Million - $21.3 Million	234,891 Added 1879.88%	247,386 $14.5 Million
Q4 2020 Feb 24, 2021	BUY	$33.89 - $49.88 $307,517 - $452,611	9,074 Added 265.24%	12,495 $581,000
Q4 2020 Feb 12, 2021	SELL	$33.89 - $49.88 $307,687 - $452,860	-9,079 Reduced 72.63%	3,421 $581,000
Q1 2020 May 13, 2020	BUY	$11.17 - $28.72 $139,625 - $359,000	12,500 New	12,500 $230,000

158

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $354M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.